Possible pathological basis for false diagnoses of lymph nodes by USPIO-enhanced MRI in rabbits

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 6, 2010, Pages 1428-1434

  Lei, Jing ^a   Xue, Hua Dan ^a   Li, Zhuo ^a   Li, Shuo ^a   Jin, Zheng Yu ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Lymph node; Molecular imaging; USPIO

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; DEXTRAN; FERRIC FERROCYANIDE; FERROCYANIDE; FERUMOXTRAN-10; MAGNETITE; MAGNETITE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTRON MICROSCOPY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HISTOPATHOLOGY; IMAGE ANALYSIS; LYMPH NODE HYPERPLASIA; LYMPH NODE METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; SENSITIVITY AND SPECIFICITY; ANIMAL; IMAGE PROCESSING; INFLAMMATION; LYMPH NODE; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY;

ANIMALS; CONTRAST MEDIA; DEXTRANS; FERROCYANIDES; FERROSOFERRIC OXIDE; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; RABBITS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77952827140     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22190     Document Type: Article

References (35)

1. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319-2331. (Pubitemid 33041104)
2. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-2499. (Pubitemid 36706536)
3. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175:494-498. (Pubitemid 20135291)
4. Michel SC, Keller TM, Fröhlich JM, et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superpara-magnetic iron oxide enhancement. Radiology 2002;225:527-536.
5. Guimaraes AR, Tabatabei S, Dahl D, McDougal WS, Weissleder R, Harisinghani MG. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology 2008;71:708-712.
6. Tokuhara T, Taniqawa N, Matsurki M, et al. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria. Gastric Cancer 2008;11:194-200.
7. Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 2003;228:777-788. (Pubitemid 37025489)
8. Memarsadeqhi M, Riedl CC, Kaneider A, et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus USPIO-enhanced MR imaging. Radiology 2006;241:367-377. (Pubitemid 44632881)
9. Sigal R, Vogl T, Casselman J, et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol 2002; 12:1104-1113. (Pubitemid 36940178)
10. Curvo-Semedo L, Diniz M, Miguéis J, et al. USPIO-enhanced magnetic resonance imaging for nodal staging in patients with head and neck cancer. J Magn Reson Imaging 2006;24:123-131.
11. Baghi M, Mack MG, Wagenblast J, et al. Iron oxide particleenhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results? Anticancer Res 2007;27:3571-3575.
12. Rockall AG, Sohaib SA, Harisinghani MG, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005;23:2813-2821. (Pubitemid 46179472)
13. Saokar A, Braschi M, Harisinghani MG. Lymphotrophic nanoparticle enhanced MR imaging (LNMR imaging) for lymph node imaging. Abdom Imaging 2006;3:660-667. (Pubitemid 46723637)
14. Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a metaanalysis. Lancet Oncol 2006;7:52-60. (Pubitemid 43025393)
15. Dünne AA, Mandic R, Ramaswamy A, et al. Lymphogenic metastatic spread of auricular VX2 carcinoma in New Zealand white rabbits. Anticancer Res 2002;22:3273-3279. (Pubitemid 36070103)
16. Koh DM, Brown G, Temple L, et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology 2004;231:91-99. (Pubitemid 38379645)
17. Harisinghani MG, Saksena MA, Hahn PF, et al. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization. Am J Roentgenol 2006;186:144-148.
18. Taniguchi I, Sakurada A, Murakami G, Suzuki D, Sato M, Kohama GI. Comparative histology of lymph node from aged animals and humans with special reference to the proportional areas of the nodal cortex and sinus. Ann Anat 2004;186:337-347. (Pubitemid 39232456)
19. Willard-Mack CL. Normal structure, function, and histology of lymph nodes. Toxicol Pathol 2006;34:409-424. (Pubitemid 44652211)
20. Harisinghani MG, Dixon WT, Saksena MA, et al. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 2004;24:867-878.
21. Choi SH, Moon WK, Hong JH, et al. Lymph node metastasis:ultrasmall superparamagnetic iron oxide enhanced MR imaging versus PET/CT in a rabbit model. Radiology 2007;242:137-143. (Pubitemid 44956018)
22. Dousset V, Gomez C, Petry KG, Delalande C, Caille JM. Dose and scanning delay using USPIO for central nervous system macrophage imaging. Magma 1999;8:185-189.
23. Corot C, Petry KG, Trivedi R, et al. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque imaging using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging, Investig Radiol 2004;39:619-625. (Pubitemid 39287601)
24. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agent for MR imaging. Radiology 1990;175:489-493. (Pubitemid 20135290)
25. Carr I. Lymphatic metastasis. Cancer Metast Rev 1983;2:307-317.
26. Lee AS, Weissleder R, Brady TJ, Wittenberg J. Lymph nodes: microstructural anatomy at MR imaging. Radiology 1991;178:519-522.
27. Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994;193:501-506. (Pubitemid 24338340)
28. Witte CL, Williams WH, Witte JH. Lymphatic imaging. Lymphology 1993;26:109-111.
29. Anzai Y, Brunberg JA, Lufkin RB. Imaging of nodal metastases in the head and neck. J Magn Reson Imaging 1997;7:774-783. (Pubitemid 28359523)
30. Pannu HK, Wang KP, Borman TL, Bluemke DA. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent. J Magn Reson Imaging 2000;12:899-904.
31. van der Brekel MW, van der Waal I, Meijer CJ, Freeman JLO, Castelijns JA, Snow GB. The incidence of micrometastases in neck dissection obtained from elective neck dissections. Laryngoscope 1996;106:987-991.
32. Tanoura T, Bernas M, Darkazanli A, et al. MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis. Am J Roentgenol 1992;159:875-881.
33. Saksena MA, Saokar A, Harisinghani MG. Lymphotropic nanoparticle enhanced MR imaging (LNMR imaging) technique for lymph node imaging. Eur J Radiol 2006;58:367-374. (Pubitemid 43729065)
34. Harishinghani MG, Saksena MA, Hahn PF, et al. Ferumoxtraon-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization. Am J Roentgenol 2006;186:144-148.
35. Harisinghani MG, Dixon WT, Saksena MA, et al. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 2004;24:867-878.